Grace & White Has Lifted By $415,000 Its Williams Sonoma Com (WSM) Holding; Wafra Investment Advisory Group Raised Biogen Idec (BIIB) Position

Williams-Sonoma, Inc. (NYSE:WSM) Logo

Wafra Investment Advisory Group Inc increased Biogen Idec Inc. (BIIB) stake by 73.18% reported in 2018Q4 SEC filing. Wafra Investment Advisory Group Inc acquired 34,724 shares as Biogen Idec Inc. (BIIB)’s stock declined 1.50%. The Wafra Investment Advisory Group Inc holds 82,175 shares with $24.73M value, up from 47,451 last quarter. Biogen Idec Inc. now has $62.94 billion valuation. The stock increased 2.32% or $7.24 during the last trading session, reaching $319.96. About 673,466 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since March 13, 2018 and is uptrending. It has outperformed by 11.54% the S&P500. Some Historical BIIB News: 14/05/2018 – Primecap Management Adds Siemens Healthineers, Cuts Biogen; 13/04/2018 – Brightwire: Biogen likely to exercise option to raise stake in Samsung Bioepis, insiders say; 12/03/2018 – Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale $BIIB $PFE; 29/05/2018 – In Search for Dip Repurchasers, Goldman Points to Apple, Biogen; 20/04/2018 – BIOGEN INC – IN COLLABORATION, IONIS WILL BE RESPONSIBLE FOR IDENTIFICATION OF ANTISENSE DRUG CANDIDATES BASED ON SELECTED TARGETS; 01/05/2018 – Biogen Will Pay $50 Million To Reduce Royalties On Alzheimer’s Disease Drug — MarketWatch; 04/05/2018 – Ionis Pharmaceuticals Expects Over $2B of Cash Upon Closing of Biogen Collaboration; 09/03/2018 – Skyland Analytics Appoints James C. Mullen, Former Biogen and Patheon CEO, to Advisory Board; 24/04/2018 – Biogen Investors Are Losing Patience — Heard on the Street; 05/04/2018 – BIOGEN & SAMSUNG BIOEPIS AGREE TO SETTLEMENT WITH ABBVIE

Grace & White Inc increased Williams Sonoma Inc Com (WSM) stake by 7.52% reported in 2018Q4 SEC filing. Grace & White Inc acquired 8,300 shares as Williams Sonoma Inc Com (WSM)’s stock rose 1.90%. The Grace & White Inc holds 118,700 shares with $5.99M value, up from 110,400 last quarter. Williams Sonoma Inc Com now has $4.58B valuation. The stock decreased 0.75% or $0.43 during the last trading session, reaching $57.1. About 864,327 shares traded. Williams-Sonoma, Inc. (NYSE:WSM) has risen 11.72% since March 13, 2018 and is uptrending. It has outperformed by 7.35% the S&P500. Some Historical WSM News: 26/04/2018 – TRISHA YEARWOOD?S BEST-SELLING ?SUMMER IN A CUP? BY WILLIAMS SONOMA WILL BE THE OFFICIAL COCKTAIL OF STAGECOACH FESTIVAL; 08/03/2018 – Williams Sonoma Celebrates International Women?s Day; 23/05/2018 – WILLIAMS-SONOMA INC WSM.N SEES FY 2018 NON-GAAP SHR $4.15 TO $4.25; 02/04/2018 – Williams-Sonoma Closes Below 200-Day Moving Average: Technicals; 15/03/2018 – Consumer Cos Flat After Sears, Williams-Sonoma Earnings — Consumer Roundup; 23/05/2018 – Williams-Sonoma 1Q Comparable Brand Rev Growth 5.5%; 14/03/2018 – WILLIAMS-SONOMA INC – SEES FULL YEAR EPS OF $4.12 – $4.22; 12/03/2018 – Williams-Sonoma Trading Activity Rises to Triple 20 Day Average; 10/05/2018 – INSCAPE CORP – ENTERED TERMINATION AGREEMENT WITH WILLIAMS-SONOMA ON BEHALF OF ITS WEST ELM BRAND, WITH AN EFFECTIVE DATE OF MAY 9, 2018; 23/05/2018 – Williams-Sonoma 1Q EPS 54c

Wafra Investment Advisory Group Inc decreased Procter & Gamble Co. (NYSE:PG) stake by 9,535 shares to 107,244 valued at $9.86M in 2018Q4. It also reduced Mondelez International Inc (NASDAQ:MDLZ) stake by 68,598 shares and now owns 699,032 shares. Citizens Financial Group (NYSE:CFG) was reduced too.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Nasdaq.com which released: “Better Buy: Amgen vs. Biogen – Nasdaq” on March 10, 2019, also Nasdaq.com with their article: “Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More – Nasdaq” published on March 06, 2019, Seekingalpha.com published: “Biogen’s Spinraza OK’d in China – Seeking Alpha” on February 28, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Seekingalpha.com and their article: “Biogen Inc. (BIIB) Presents at Cowen 39th Annual Health Care Conference (Transcript) – Seeking Alpha” published on March 12, 2019 as well as Nasdaq.com‘s news article titled: “NITE, BIIB: Nightstar Therapeutics Stock Soars on Biogen Buy – Nasdaq” with publication date: March 04, 2019.

Investors sentiment decreased to 0.91 in 2018 Q4. Its down 0.10, from 1.01 in 2018Q3. It dropped, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. Triangle Securities Wealth Mngmt owns 6,753 shares for 1.2% of their portfolio. Ing Groep Nv has 62,782 shares for 0.41% of their portfolio. M&T Bank reported 78,442 shares. Balyasny Asset Limited Company accumulated 106,566 shares. Covington Cap Mgmt holds 0% in Biogen Inc. (NASDAQ:BIIB) or 138 shares. Somerset Tru owns 56 shares or 0.01% of their US portfolio. Montrusco Bolton Invs Inc holds 1.22% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 60,607 shares. Hilton Capital Management Limited Liability Company reported 15 shares. Argent Mgmt holds 1.32% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 87,154 shares. Next Financial Group has invested 0.02% in Biogen Inc. (NASDAQ:BIIB). Capital Interest Ca has invested 0.54% in Biogen Inc. (NASDAQ:BIIB). Levin Cap Strategies Lp holds 0.02% or 3,728 shares in its portfolio. Meiji Yasuda Life Ins Com has 5,959 shares for 0.28% of their portfolio. Amalgamated Commercial Bank reported 29,385 shares. Wealthtrust Axiom Limited Liability Corp accumulated 920 shares.

Among 11 analysts covering Biogen (NASDAQ:BIIB), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. Biogen had 14 analyst reports since October 1, 2018 according to SRatingsIntel. The stock has “Buy” rating by H.C. Wainwright on Tuesday, March 5. Morgan Stanley maintained it with “Overweight” rating and $401 target in Wednesday, December 19 report. The stock has “Buy” rating by Cantor Fitzgerald on Monday, March 4. Cantor Fitzgerald maintained Biogen Inc. (NASDAQ:BIIB) rating on Monday, October 1. Cantor Fitzgerald has “Overweight” rating and $400 target. The company was maintained on Monday, March 4 by Cowen & Co. The firm earned “Overweight” rating on Wednesday, October 24 by JP Morgan. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Neutral” rating by Guggenheim on Friday, February 22. On Tuesday, February 19 the stock rating was maintained by H.C. Wainwright with “Buy”. The firm earned “Market Perform” rating on Friday, October 19 by Bernstein. Stifel Nicolaus downgraded Biogen Inc. (NASDAQ:BIIB) on Thursday, February 21 to “Hold” rating.

Since September 26, 2018, it had 1 insider buy, and 1 insider sale for $20.22 million activity. 62,800 Biogen Inc. (NASDAQ:BIIB) shares with value of $20.57 million were bought by DENNER ALEXANDER J. Ehlers Michael D sold $350,000 worth of stock.

Among 5 analysts covering Williams-Sonoma (NYSE:WSM), 1 have Buy rating, 1 Sell and 3 Hold. Therefore 20% are positive. Williams-Sonoma had 7 analyst reports since October 11, 2018 according to SRatingsIntel. As per Thursday, October 11, the company rating was maintained by Morgan Stanley. The firm earned “Neutral” rating on Friday, November 16 by Buckingham Research. Citigroup maintained Williams-Sonoma, Inc. (NYSE:WSM) rating on Wednesday, November 21. Citigroup has “Neutral” rating and $58 target. The firm earned “Hold” rating on Friday, November 16 by Deutsche Bank. The firm has “Underweight” rating by Morgan Stanley given on Wednesday, January 23. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, November 23.

More notable recent Williams-Sonoma, Inc. (NYSE:WSM) news were published by: Investorplace.com which released: “Like Its Stores, JCPenney Stock May Simply Be Too Far Gone to Salvage – Investorplace.com” on March 13, 2019, also Seekingalpha.com with their article: “Stocks To Watch: Big Intros For Model Y And Captain Marvel? – Seeking Alpha” published on March 09, 2019, Fool.com published: “Walmart’s Latest Move Could Hurt Bed Bath & Beyond – Motley Fool” on February 14, 2019. More interesting news about Williams-Sonoma, Inc. (NYSE:WSM) were released by: Globenewswire.com and their article: “Detailed Research: Economic Perspectives on Novartis AG, Proteostasis Therapeutics, Williams-Sonoma, Magna International, YRC Worldwide, and Delek Logistics Partners — What Drives Growth in Today’s Competitive Landscape – GlobeNewswire” published on February 25, 2019 as well as Bizjournals.com‘s news article titled: “West Elm coming to Pike & Rose – Washington – Washington Business Journal” with publication date: February 15, 2019.

Williams-Sonoma, Inc. (NYSE:WSM) Institutional Positions Chart